RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,176,835 | -59.7% | 377,745 | -39.8% | 0.02% | -56.8% |
| Q2 2023 | $7,875,283 | +7.8% | 627,013 | +41.3% | 0.04% | -12.0% |
| Q1 2023 | $7,306,520 | +3.1% | 443,626 | -6.5% | 0.05% | -15.3% |
| Q4 2022 | $7,085,728 | +61.5% | 474,279 | +141.8% | 0.06% | +25.5% |
| Q3 2022 | $4,387,000 | +43.8% | 196,119 | +7.7% | 0.05% | +67.9% |
| Q2 2022 | $3,050,000 | -40.1% | 182,098 | +6.9% | 0.03% | -6.7% |
| Q1 2022 | $5,096,000 | -12.7% | 170,274 | -10.4% | 0.03% | -3.2% |
| Q4 2021 | $5,835,000 | +90.6% | 190,002 | +95.7% | 0.03% | +47.6% |
| Q3 2021 | $3,061,000 | +9.8% | 97,096 | +27.4% | 0.02% | +16.7% |
| Q2 2021 | $2,789,000 | -4.9% | 76,225 | -10.1% | 0.02% | -10.0% |
| Q1 2021 | $2,932,000 | +543.0% | 84,809 | +673.2% | 0.02% | +400.0% |
| Q4 2020 | $456,000 | – | 10,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |